{
  "zip": "77014",
  "sector": "",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Oncolix, Inc., a clinical-stage biopharmaceutical company, engages in developing medical therapies for the treatment of cancer in the United States. It is developing Prolanta, a biological drug that is in Phase I clinical trial for the treatment of ovarian cancer. The company was formerly known as Advanced Environmental Petroleum Producers, Inc. and changed its name to Oncolix, Inc. in September 2017. Oncolix, Inc. was founded in 2007 and is based in Houston, Texas.",
  "city": "Houston",
  "phone": "281-402-3167",
  "state": "TX",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.oncolixbio.com",
  "maxAge": 1,
  "address1": "14405 Walters Road",
  "industry": "",
  "address2": "Suite 780",
  "previousClose": 0.0001,
  "regularMarketOpen": 0.0001,
  "twoHundredDayAverage": 9.5289855e-05,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0001,
  "navPrice": null,
  "averageDailyVolume10Day": 4366551,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0001,
  "fiftyDayAverage": 0.0001,
  "trailingAnnualDividendRate": null,
  "open": 0.0001,
  "averageVolume10days": 4366551,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 190.16357,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0001,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1400000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 51224,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 2682023,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.0001,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1400000,
  "fiftyTwoWeekHigh": 0.0001,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1e-05,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0001,
  "exchange": "PNK",
  "shortName": "ONCOLIX INC",
  "longName": "Oncolix, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ONCX",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_51621512",
  "uuid": "03de6392-d755-356e-aa7b-8cd4f5ee95d5",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 512259008,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.067,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1514678400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -8041252,
  "trailingEps": -0.077,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1577750400,
  "mostRecentQuarter": 1538265600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 100313831,
  "enterpriseValue": 6102098,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1444694400,
  "lastSplitFactor": "1:1000",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0001,
  "logo_url": "https://logo.clearbit.com/oncolixbio.com"
}